These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 36522333)

  • 1. Multi-omics identify falling LRRC15 as a COVID-19 severity marker and persistent pro-thrombotic signals in convalescence.
    Gisby JS; Buang NB; Papadaki A; Clarke CL; Malik TH; Medjeral-Thomas N; Pinheiro D; Mortimer PM; Lewis S; Sandhu E; McAdoo SP; Prendecki MF; Willicombe M; Pickering MC; Botto M; Thomas DC; Peters JE
    Nat Commun; 2022 Dec; 13(1):7775. PubMed ID: 36522333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human Endogenous Retrovirus (HERV) Transcriptome Is Dynamically Modulated during SARS-CoV-2 Infection and Allows Discrimination of COVID-19 Clinical Stages.
    Grandi N; Erbì MC; Scognamiglio S; Tramontano E
    Microbiol Spectr; 2023 Feb; 11(1):e0251622. PubMed ID: 36602345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sequential multi-omics analysis identifies clinical phenotypes and predictive biomarkers for long COVID.
    Wang K; Khoramjoo M; Srinivasan K; Gordon PMK; Mandal R; Jackson D; Sligl W; Grant MB; Penninger JM; Borchers CH; Wishart DS; Prasad V; Oudit GY
    Cell Rep Med; 2023 Nov; 4(11):101254. PubMed ID: 37890487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Multi-omics Longitudinal Study Reveals Alteration of the Leukocyte Activation Pathway in COVID-19 Patients.
    Suvarna K; Salkar A; Palanivel V; Bankar R; Banerjee N; Gayathri J Pai M; Srivastava A; Singh A; Khatri H; Agrawal S; Shrivastav O; Shastri J; Srivastava S
    J Proteome Res; 2021 Oct; 20(10):4667-4680. PubMed ID: 34379420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multi-omic and comparative analyses revealed monocyte-derived alpha-defensin-1 correlated with COVID-19 severity and inhibited SARS-CoV-2 infection.
    Qian X; Wu B; Chen X; Peng H; Liu M; Tang H; Xu Z; Xu C; Qi Z
    J Med Virol; 2023 Jun; 95(6):e28845. PubMed ID: 37254949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Randomized Open label Phase-II Clinical Trial with or without Infusion of Plasma from Subjects after Convalescence of SARS-CoV-2 Infection in High-Risk Patients with Confirmed Severe SARS-CoV-2 Disease (RECOVER): A structured summary of a study protocol for a randomised controlled trial.
    Janssen M; Schäkel U; Djuka Fokou C; Krisam J; Stermann J; Kriegsmann K; Haberbosch I; Novotny JP; Weber S; Vehreschild M; Bornhäuser M; Bullinger L; Schmitt M; Liebregts T; Dreger P; Lorenz HM; Plaszczyca A; Bartenschlager R; Müller B; Kräusslich HG; Halama N; Jäger D; Schlenk RF; Leo A; Meuer S; Weigand MA; Motsch J; Merle U; Denkinger CM; Müller-Tidow C
    Trials; 2020 Oct; 21(1):828. PubMed ID: 33023671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multi-Omics Integration Reveals Only Minor Long-Term Molecular and Functional Sequelae in Immune Cells of Individuals Recovered From COVID-19.
    Liu Z; Kilic G; Li W; Bulut O; Gupta MK; Zhang B; Qi C; Peng H; Tsay HC; Soon CF; Mekonnen YA; Ferreira AV; van der Made CI; van Cranenbroek B; Koenen HJPM; Simonetti E; Diavatopoulos D; de Jonge MI; Müller L; Schaal H; Ostermann PN; Cornberg M; Eiz-Vesper B; van de Veerdonk F; van Crevel R; Joosten LAB; Domínguez-Andrés J; Xu CJ; Netea MG; Li Y
    Front Immunol; 2022; 13():838132. PubMed ID: 35464396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multi-omic longitudinal study reveals immune correlates of clinical course among hospitalized COVID-19 patients.
    Diray-Arce J; Fourati S; Doni Jayavelu N; Patel R; Maguire C; Chang AC; Dandekar R; Qi J; Lee BH; van Zalm P; Schroeder A; Chen E; Konstorum A; Brito A; Gygi JP; Kho A; Chen J; Pawar S; Gonzalez-Reiche AS; Hoch A; Milliren CE; Overton JA; Westendorf K; ; Cairns CB; Rouphael N; Bosinger SE; Kim-Schulze S; Krammer F; Rosen L; Grubaugh ND; van Bakel H; Wilson M; Rajan J; Steen H; Eckalbar W; Cotsapas C; Langelier CR; Levy O; Altman MC; Maecker H; Montgomery RR; Haddad EK; Sekaly RP; Esserman D; Ozonoff A; Becker PM; Augustine AD; Guan L; Peters B; Kleinstein SH
    Cell Rep Med; 2023 Jun; 4(6):101079. PubMed ID: 37327781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple early factors anticipate post-acute COVID-19 sequelae.
    Su Y; Yuan D; Chen DG; Ng RH; Wang K; Choi J; Li S; Hong S; Zhang R; Xie J; Kornilov SA; Scherler K; Pavlovitch-Bedzyk AJ; Dong S; Lausted C; Lee I; Fallen S; Dai CL; Baloni P; Smith B; Duvvuri VR; Anderson KG; Li J; Yang F; Duncombe CJ; McCulloch DJ; Rostomily C; Troisch P; Zhou J; Mackay S; DeGottardi Q; May DH; Taniguchi R; Gittelman RM; Klinger M; Snyder TM; Roper R; Wojciechowska G; Murray K; Edmark R; Evans S; Jones L; Zhou Y; Rowen L; Liu R; Chour W; Algren HA; Berrington WR; Wallick JA; Cochran RA; Micikas ME; ; Wrin T; Petropoulos CJ; Cole HR; Fischer TD; Wei W; Hoon DSB; Price ND; Subramanian N; Hill JA; Hadlock J; Magis AT; Ribas A; Lanier LL; Boyd SD; Bluestone JA; Chu H; Hood L; Gottardo R; Greenberg PD; Davis MM; Goldman JD; Heath JR
    Cell; 2022 Mar; 185(5):881-895.e20. PubMed ID: 35216672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sustained VWF-ADAMTS-13 axis imbalance and endotheliopathy in long COVID syndrome is related to immune dysfunction.
    Fogarty H; Ward SE; Townsend L; Karampini E; Elliott S; Conlon N; Dunne J; Kiersey R; Naughton A; Gardiner M; Byrne M; Bergin C; O'Sullivan JM; Martin-Loeches I; Nadarajan P; Bannan C; Mallon PW; Curley GF; Preston RJS; Rehill AM; Baker RI; Cheallaigh CN; O'Donnell JS;
    J Thromb Haemost; 2022 Oct; 20(10):2429-2438. PubMed ID: 35875995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteomic analysis of circulating immune cells identifies cellular phenotypes associated with COVID-19 severity.
    Potts M; Fletcher-Etherington A; Nightingale K; Mescia F; Bergamaschi L; Calero-Nieto FJ; Antrobus R; Williamson J; ; Parsons H; Huttlin EL; Kingston N; Göttgens B; Bradley JR; Lehner PJ; Matheson NJ; Smith KGC; Wills MR; Lyons PA; Weekes MP
    Cell Rep; 2023 Jun; 42(6):112613. PubMed ID: 37302069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early immune markers of clinical, virological, and immunological outcomes in patients with COVID-19: a multi-omics study.
    Hu Z; van der Ploeg K; Chakraborty S; Arunachalam PS; Mori DAM; Jacobson KB; Bonilla H; Parsonnet J; Andrews JR; Holubar M; Subramanian A; Khosla C; Maldonado Y; Hedlin H; de la Parte L; Press K; Ty M; Tan GS; Blish C; Takahashi S; Rodriguez-Barraquer I; Greenhouse B; Butte AJ; Singh U; Pulendran B; Wang TT; Jagannathan P
    Elife; 2022 Oct; 11():. PubMed ID: 36239699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multi-omic profiling reveals early immunological indicators for identifying COVID-19 Progressors.
    Drake KA; Talantov D; Tong GJ; Lin JT; Verheijden S; Katz S; Leung JM; Yuen B; Krishna V; Wu MJ; Sutherland AM; Short SA; Kheradpour P; Mumbach MR; Franz KM; Trifonov V; Lucas MV; Merson J; Kim CC;
    Clin Immunol; 2023 Nov; 256():109808. PubMed ID: 37852344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peripheral blood mononuclear cell tissue factor (F3 gene) transcript levels and circulating extracellular vesicles are elevated in severe coronavirus 2019 (COVID-19) disease.
    Girard TJ; Antunes L; Zhang N; Amrute JM; Subramanian R; Eldem I; Remy KE; Mazer M; Erlich EC; Cruchaga C; Steed AL; Randolph GJ; Di Paola J
    J Thromb Haemost; 2023 Mar; 21(3):629-638. PubMed ID: 36696180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteomics of extracellular vesicles in plasma reveals the characteristics and residual traces of COVID-19 patients without underlying diseases after 3 months of recovery.
    Mao K; Tan Q; Ma Y; Wang S; Zhong H; Liao Y; Huang Q; Xiao W; Xia H; Tan X; Luo P; Xu J; Long D; Jin Y
    Cell Death Dis; 2021 May; 12(6):541. PubMed ID: 34035220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single-cell multi-omics analysis of COVID-19 patients with pre-existing autoimmune diseases shows aberrant immune responses to infection.
    Barmada A; Handfield LF; Godoy-Tena G; de la Calle-Fabregat C; Ciudad L; Arutyunyan A; Andrés-León E; Hoo R; Porter T; Oszlanczi A; Richardson L; Calero-Nieto FJ; Wilson NK; Marchese D; Sancho-Serra C; Carrillo J; Presas-Rodríguez S; Ramo-Tello C; Ruiz-Sanmartin A; Ferrer R; Ruiz-Rodriguez JC; Martínez-Gallo M; Munera-Campos M; Carrascosa JM; Göttgens B; Heyn H; Prigmore E; Casafont-Solé I; Solanich X; Sánchez-Cerrillo I; González-Álvaro I; Raimondo MG; Ramming A; Martin J; Martínez-Cáceres E; Ballestar E; Vento-Tormo R; Rodríguez-Ubreva J
    Eur J Immunol; 2024 Jan; 54(1):e2350633. PubMed ID: 37799110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Longitudinal proteomic profiling of dialysis patients with COVID-19 reveals markers of severity and predictors of death.
    Gisby J; Clarke CL; Medjeral-Thomas N; Malik TH; Papadaki A; Mortimer PM; Buang NB; Lewis S; Pereira M; Toulza F; Fagnano E; Mawhin MA; Dutton EE; Tapeng L; Richard AC; Kirk PD; Behmoaras J; Sandhu E; McAdoo SP; Prendecki MF; Pickering MC; Botto M; Willicombe M; Thomas DC; Peters JE
    Elife; 2021 Mar; 10():. PubMed ID: 33704068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Longitudinal assessment of anti-SARS-CoV-2 antibody dynamics and clinical features following convalescence from a COVID-19 infection.
    Gerhards C; Thiaucourt M; Kittel M; Becker C; Ast V; Hetjens M; Neumaier M; Haselmann V
    Int J Infect Dis; 2021 Jun; 107():221-227. PubMed ID: 33932604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Convalescent COVID-19 Patients Without Comorbidities Display Similar Immunophenotypes Over Time Despite Divergent Disease Severities.
    Chu CF; Sabath F; Fibi-Smetana S; Sun S; Öllinger R; Noeßner E; Chao YY; Rinke L; Winheim E; Rad R; Krug AB; Taher L; Zielinski CE
    Front Immunol; 2021; 12():601080. PubMed ID: 34867933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single-cell transcriptomic atlas reveals distinct immunological responses between COVID-19 vaccine and natural SARS-CoV-2 infection.
    Wang Y; Wang X; Luu LDW; Li J; Cui X; Yao H; Chen S; Fu J; Wang L; Wang C; Yuan R; Cai Q; Huang X; Huang J; Li Z; Li S; Zhu X; Tai J
    J Med Virol; 2022 Nov; 94(11):5304-5324. PubMed ID: 35859327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.